Clinical Trial Update: ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

View source ↗

Summary

A postmarketing surveillance registry assessing the safety and performance of the everolimus-eluting bioresorbable vascular scaffold in patients with coronary a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arteriosclerosis
• Coronary Artery Disease
• Coronary Restenosis
• Coronary Stenosis
• Myocardial Ischemia

Drugs mentioned

• ABSORB Everolimus-eluting bioresorbable vascular scaffold (everolimus-eluting bioresorbable vascular scaffold)

Snippet

Sponsor: Medical Care Center Prof. Mathey, Prof. Schofer, Ltd. | Conditions: Cardiovascular Diseases, Coronary Artery Disease | Status: COMPLETED